OTC Healthcare in China
Euromonitor International's OTC Healthcare in China market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 107 | Publication date: Sep 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Strong growth due to rising incomes and awareness
There was strong growth across OTC healthcare in 2006. Growth was supported by continued expansion in the Chinese economy, with rising income levels enabling consumers to buy more OTC healthcare. This drove growth in basic products such as analgesics and cough, cold and allergy (hay fever) remedies. Rising incomes also resulted in richer and less healthy diets, boosting digestive remedies, while increased pollution supported growth in allergy remedies and medicated skin care. In addition, consumers became more aware of OTC healthcare and more confident in self-medication, while health and wellness trends boosted vitamins and dietary supplements. Consumers also became more confident in discussing once-taboo ailments, with this boosting products such as vaginal antifungals and haemorrhoid treatments.
Emergency contraception benefits from government campaigns
Emergency contraception saw the strongest current value growth in 2006 over the previous year. Growth was supported by strong government campaigns and by advertising. As condoms cannot currently be advertised in the country, emergency contraception was left with a distinct advantage. In addition, women generally became more confident and affluent during the review period, leaving them in a better position to direct their own birth control.
Amway leads despite difficulties
Amway remained the leading player in 2006, with a share considerably higher than any of its competitors. This was despite seeing a sharp drop in share over 2005, as it attempted to reconcile its sales representatives to a new business structure in line with new direct sales legislation. Amway is only present in vitamins and dietary supplements, which dominates overall OTC healthcare. Direct sales is particularly strong in vitamins and dietary supplements, due to its representatives being able to offer individual guidance to often-confused customers and with distribution expanding rapidly across the country.
Specialist channels continue to dominate
Chemists/pharmacies and drugstores/parapharmacies jointly dominated value sales of OTC healthcare in 2006. Many OTC healthcare products are indeed only permitted for sale via these channels. However, these channels both lost share during the review period as distribution widened for many products. Discounters notably gained share across OTC healthcare in the latter half of the review period, as this channel’s low prices appealed to price-sensitive consumers. Direct sales also gained share rapidly, due to its growing presence in dominant vitamins and dietary supplements.
Good growth to continue as distribution and self-medication widens
OTC healthcare is expected to see slower but still strong growth during the forecast period. Many products are seeing increasing maturity in larger cities, notably analgesics and vitamins and dietary supplements, with this expected to dampen growth. Growth will continue to be supported by distribution widening to include smaller cities and rural areas, however. In addition, growth will be boosted by consumers’ growing confidence in self-medication, with most happy to choose basic OTC healthcare themselves.
Table of contents
OTC HEALTHCARE IN CHINA : MARKET INSIGHT
EXECUTIVE SUMMARY
Strong growth due to rising incomes and awareness
Emergency contraception benefits from government campaigns
Amway leads despite difficulties
Specialist channels continue to dominate
Good growth to continue as distribution and self-medication widens
KEY TRENDS AND DEVELOPMENTS
Rising income levels boost sales
Traditional Chinese medicine continues to grow in popularity
Growing interest in self-medication and health and wellness
Grooming and appearance become increasingly important
Specialist channels see dominance eroded
TERRITORY KEY TRENDS AND DEVELOPMENTS
East China
Mid China
North and Northeast China
Northwest China
South China
Southwest China
MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 Sales of OTC Healthcare by Region: Value 2001-2006
Table 5 Sales of OTC Healthcare by Region: % Value Growth 2001-2006
Table 6 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 7 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
Table 12 Forecast Sales of OTC Healthcare by Region: Value 2006-2011
Table 13 Forecast Sales of OTC Healthcare by Region: % Value Growth 2006-2011
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Generics
Consumer expenditure on health goods and medical services
Consumer Expenditure on Health Goods and Medical Services
Table 14 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
LOCAL COMPANY PROFILES - CHINA
AMWAY (CHINA) CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Amway (China) Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 3 Amway (China) Co Ltd: Competitive Position 2006
BRISTOL-MYERS SQUIBB CO - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Key Facts
Summary 5 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 6 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Competitive Position 2006
GUANGZHOU PAN GAO SHOU PHARM CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Guangzhou Pan Gao Shou Pharm Co Ltd: Key Facts
Summary 8 Guangzhou Pan Gao Shou Pharm Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 9 Guangzhou Pan Gao Shou Pharm Co Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 10 Guangzhou Pan Gao Shou Pharm Co Ltd: Competitive Position 2006
HARBIN PHARMACEUTICAL GROUP SANJING PHARM CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Harbin Pharmaceutical Group Sanjing Pharm Co Ltd: Key Facts
Summary 12 Harbin Pharmaceutical Group Sanjing Pharm Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 13 Harbin Pharmaceutical Group Sanjing Pharm Co Ltd: Competitive Position 2006
KUNMING DIANHONG PHARM CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 14 Kunming Dianhong Pharm Co Ltd: Key Facts
Summary 15 Kunming Dianhong Pharm Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 16 Kunming Dianhong Pharm Co Ltd: Competitive Position 2006
SHANGHAI JIAO DA ONLLY CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 17 Shanghai Jiao Da Onlly Co Ltd: Key Facts
Summary 18 Shanghai Jiao Da Onlly Co Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 19 Shanghai Jiao Da Onlly Co Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 20 Shanghai Jiao Da Onlly Co Ltd: Competitive Position 2006
TIANJIN TIANSHI BIOLOGICAL DEVELOPMENT CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 21 Tianjin Tianshi Biological Development Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 22 Tianjin Tianshi Biological Development Co Ltd: Competitive Position 2006
TIBET LINZHI QIZHENG TIBETAN MEDICINE FTY - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 23 Tibet Linzhi Qizheng Tibetan Medicine Fty: Key Facts
Summary 24 Tibet Linzhi Qizheng Tibetan Medicine Fty: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 25 Tibet Linzhi Qizheng Tibetan Medicine Fty: Competitive Position 2006
WYETH PHARMACEUTICAL CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 26 Wyeth Pharmaceutical Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 27 Summary Wyeth Pharmaceutical Co Ltd: Competitive Position 2006
XIAN JANSSEN PHARMACEUTICAL LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 28 Xian Janssen Pharmaceutical Ltd: Key Facts
Summary 29 Xian Janssen Pharmaceutical Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 30 Xian Janssen Pharmaceutical Ltd: Competitive Position 2006
ANALGESICS IN CHINA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 15 Sales of Analgesics by Subsector: Value 2001-2006
Table 16 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 17 Herbal vs Standard Topical Analgesics 2001/2006
Table 18 Analgesics Company Shares by Retail Value 2002-2006
Table 19 Analgesics Brand Shares by Retail Value 2003-2006
Table 20 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 21 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN CHINA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 22 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 23 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 24 Sales of Decongestants by Type: Value 2001-2006
Table 25 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 26 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
Table 27 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
Table 28 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 29 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 30 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 31 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 32 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
DIGESTIVE REMEDIES IN CHINA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 33 Sales of Digestive Remedies by Subsector: Value 2001-2006
Table 34 Sales of Digestive Remedies by Subsector: % Value Growth 2001-2006
Table 35 Herbal vs Standard Digestive Remedies 2001/2006
Table 36 Digestive Remedies Company Shares by Retail Value 2002-2006
Table 37 Digestive Remedies Brand Shares by Retail Value 2003-2006
Table 38 Forecast Sales of Digestive Remedies by Subsector: Value 2006-2011
Table 39 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2006-2011
MEDICATED SKIN CARE IN CHINA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 40 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 41 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 42 Herbal vs Standard Medicated Skin Care 2001/2006
Table 43 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 44 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 45 Acne Treatments Brand Shares by Retail Value 2003-2006
Table 46 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 47 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
VITAMINS AND DIETARY SUPPLEMENTS IN CHINA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
Table 49 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
Table 50 Sales of Vitamins by Type: Value 2001-2006
Table 51 Sales of Vitamins by Type: % Value Growth 2001-2006
Table 52 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
Table 53 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 54 Vitamins Brand Shares by Retail Value 2003-2006
Table 55 Sales of Dietary Supplements by Type: Value 2001-2006
Table 56 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
Table 57 Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 58 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
Table 59 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
NRT SMOKING CESSATION AIDS IN CHINA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 60 Number of Smokers by Gender 2001-2006
SECTOR DATA
Table 61 Sales of Smoking Cessation Aids by Subsector 2001-2006
EYE CARE IN CHINA
HEADLINES
SECTOR DATA
Table 62 Sales of Eye Care by Subsector: Value 2001-2006
Table 63 Sales of Eye Care by Subsector: % Value Growth 2001-2006
Table 64 Eye Care Company Shares by Retail Value 2002-2006
Table 65 Eye Care Brand Shares by Retail Value 2003-2006
Table 66 Forecast Sales of Eye Care by Subsector: Value 2006-2011
Table 67 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011
EAR CARE IN CHINA
HEADLINES
ADULT MOUTHCARE IN CHINA
HEADLINES
CALMING AND SLEEPING PRODUCTS IN CHINA
HEADLINES
WOUND TREATMENTS IN CHINA
HEADLINES
SECTOR DATA
Table 68 Sales of Wound Treatments by Subsector: Value 2001-2006
Table 69 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
Table 70 Wound Treatments Company Shares by Retail Value 2002-2006
Table 71 Wound Treatments Brand Shares by Retail Value 2003-2006
Table 72 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
Table 73 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011
EMERGENCY CONTRACEPTION IN CHINA
HEADLINES
SECTOR DATA
Table 74 Sales of Emergency Contraception by Subsector: Value 2001-2006
Table 75 Sales of Emergency Contraception by Subsector: % Value Growth 2001-2006
Table 76 Forecast Sales of Emergency Contraception by Subsector: Value 2006-2011
Table 77 Forecast Sales of Emergency Contraception by Subsector: % Value Growth 2006-2011